PROCEPT BioRobotics CorporationPRCT

$21.72+0.81 (+3.87%)
NASDAQHealthcare24:00 UTC

How much the market pays relative to the company's accounting net worth (assets minus liabilities). P/B < 1 means the market values the company below what the books say it owns.

FormulaPrice / Book Value Per Share
Full guide

P/B History

Historically priceyAbove avgAround avgBelow avgHistorically cheap
No data available
How to read this chart

Most useful for asset-heavy businesses: banks, insurers, REITs. A P/B near its historical low suggests the market is paying unusually little for the net assets.

Key caveats
  • Goodwill and intangibles from acquisitions can inflate book value significantly — some analysts prefer tangible book value.
  • Low P/B in technology or software companies is usually irrelevant: their value is in IP and people, not balance sheet assets.

Is PRCT P/B High or Low Right Now?

PROCEPT BioRobotics Corporation's P/B is currently 3.5, which is near historic low relative to its 10-year historical range. The 10-year median P/B for PRCT is approximately 7.8. See all PRCT valuation metrics →

Pro — up to 30-year history

Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.